Association of blood levels of components of the urokinase system of plasminogen activation with prostate cancer presence, invasion, progression, and metastasis

被引：0
|
作者：
Shariat, Shahrokh F.
Roehrbom, Claus G.
McConnell, John D.
Park, Sangtae
Wheeler, Thomas M.
Slawin, Kevin M.
机构：
来源：
JOURNAL OF UROLOGY | 2007年 / 177卷 / 04期
关键词：
D O I：
10.1016/S0022-5347(18)31634-3
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：473 / 473
页数：1
相关论文
共 50 条
  • [21] Modulators of the urokinase-type plasminogen activation system for cancer
    Rosenberg, S
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2000, 10 (12) : 1843 - 1852
  • [22] The urokinase-type plasminogen activator system in cancer metastasis: A review
    Andreasen, PA
    Kjoller, L
    Christensen, L
    Duffy, MJ
    INTERNATIONAL JOURNAL OF CANCER, 1997, 72 (01) : 1 - 22
  • [23] Targeting the urokinase plasminogen activation pathway reduces PDAC cancer progression.
    Chowdhury, Nayela N.
    Yang, Yi
    Shen, Yingnan
    Davey, Keely G.
    Han, Bumsoo
    Wolberg, Alisa
    Flick, Matthew J.
    Fishel, Melissa L.
    CANCER RESEARCH, 2021, 81 (13)
  • [24] UROKINASE PLASMINOGEN-ACTIVATOR IS NECESSARY BUT NOT SUFFICIENT FOR PROSTATE-CANCER CELL INVASION
    JARRARD, DF
    HANSEN, NM
    PATAI, B
    RUKSTALIS, DB
    INVASION & METASTASIS, 1995, 15 (1-2): : 34 - 45
  • [25] Multifunctional potential of the plasminogen activation system in tumor invasion and metastasis (Review)
    Reuning, U
    Magdolen, V
    Wilhelm, O
    Fischer, K
    Lutz, V
    Graeff, H
    Schmitt, M
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1998, 13 (05) : 893 - 906
  • [26] Inhibition of invasion and metastasis in oral cancer by targeting urokinase-type plasminogen activator receptor
    Nozaki, S
    Endo, Y
    Nakahara, H
    Yoshizawa, K
    Hashiba, Y
    Kawashiri, S
    Tanaka, A
    Nakagawa, K
    Matsuoka, Y
    Kogo, M
    Yamamoto, E
    ORAL ONCOLOGY, 2005, 41 (10) : 971 - 977
  • [27] Association of Tissue mRNA and Serum Antigen Levels of Members of the Urokinase-Type Plasminogen Activator System with Clinical and Prognostic Parameters in Prostate Cancer
    Al-Janabi, Omar
    Taubert, Helge
    Lohse-Fischer, Andrea
    Froehner, Michael
    Wach, Sven
    Stoehr, Robert
    Keck, Bastian
    Burger, Max
    Wieland, Wolf
    Erdmann, Kati
    Wirth, Manfred P.
    Wullich, Bernd
    Baretton, Gustavo
    Magdolen, Viktor
    Kotzsch, Matthias
    Fuessel, Susanne
    BIOMED RESEARCH INTERNATIONAL, 2014, 2014
  • [28] The urokinase system of plasminogen activation and prognosis in 2780 breast cancer patients
    Foekens, JA
    Peters, HA
    Look, MP
    Portengen, H
    Schmitt, M
    Kramer, MD
    Brünner, N
    Jänicke, F
    Meijer-van Gelder, ME
    Henzen-Logmans, SC
    van Putten, WLJ
    Klijn, JGM
    CANCER RESEARCH, 2000, 60 (03) : 636 - 643
  • [29] ASSOCIATION BETWEEN THE UROKINASE PLASMINOGEN ACTIVATION SYSTEM POLYMORPHISMS AND NSCLC IN CHINESE POPULATION
    Gu, Jianzhong
    Shen, Yingying
    Xu, Binyue
    Zhan, Yu
    Guo, Yong
    ACTA MEDICA MEDITERRANEA, 2021, 37 (02): : 935 - 940
  • [30] Polymorphisms in the genes of the urokinase plasminogen activation system in relation to colorectal cancer
    Foersti, A.
    Lei, H.
    Tavelin, B.
    Enquist, K.
    Palmqvist, R.
    Altieri, A.
    Hallmans, G.
    Hemminki, K.
    Lenner, P.
    ANNALS OF ONCOLOGY, 2007, 18 (12) : 1990 - 1994
12345